FDA 'Priority Voucher' Program Comes Under Congressional Scrutiny

FDA 'Priority Voucher' Program Comes Under Congressional Scrutiny

(MedPage Today) -- Two members of Congress launched an investigation into FDA Commissioner Marty Makary, MD, MPH, and his use of "priority vouchers" for expedited drug approvals, suggesting that the voucher program "could undermine public confidence...

Skin Cancer Breakthrough? Pharma Firm Seeks Fast-Track FDA Voucher for Novel Patch

PHILADELPHIA, PA — Medicus Pharma Ltd. (NASDAQ: MDCX) has submitted a federal priority-review request for its investigational SkinJect microneedle patch, a dissolvable doxorubicin-based therapy designed to non-invasively treat basal cell carcinoma, the most common cancer in the United States. The application asks the U.S. Food and Drug Administration to grant a Commissioner’s National Priority Voucher, a newly launched program intended to accele…

FDA 'Priority Voucher' Program Comes Under Congressional Scrutiny

(MedPage Today) — Two members of Congress launched an investigation into FDA Commissioner Marty Makary, MD, MPH, and his use of “priority vouchers” for expedited drug approvals, suggesting that the voucher program “could undermine public confidence… Source link : https://www.medpagetoday.com/publichealthpolicy/fdageneral/118690 Author : Publish date : 2025-11-24 22:23:00 Copyright for syndicated content belongs to the linked […] The post FDA ‘Pr…

FDA's Pazdur questions legality of voucher program, sources say, in latest internal disagreement

That didn't take long. Less than two weeks since appointing Richard Pazdur to lead the FDA's drug center, Commissioner Marty Makary is already finding himself in disagreement with his new deputy, according to two people ...